Back to Authors

Mookadam, Martina

https://orcid.org/0000-0002-4802-9510

Mayo Clinic

Mayo Clinic in Arizona

Citations 21

Caveolin-1 Can Regulate Vascular Smooth Muscle Cell Fate by Switching Platelet-Derived Growth Factor Signaling From a Proliferative to an Apoptotic Pathway
Peterson, Timothy E., Guicciardi, Maria Eugenia , Gulati, Rajiv , Kleppe, Laurel S., Mueske, Cheryl S., Mookadam, Martina , Sowa, Grzegorz , Sessa, William C. , Simari, Robert D., Gores, Gregory J.

Arteriosclerosis, Thrombosis, and Vascular Biology | June 24, 2003 | Volume: 23 | Issue: 9 | Pages: 1521-1527

10.1161/01.atv.0000081743.35125.05 Get It

Background— Caveolin-1 is a regulator of signaling events originating from plasma membrane microdomains termed caveolae. This study was performed to determine the regulatory role of caveolin-1 on the proliferative events induced by platelet-derived growth factor (PDGF) in vascular smooth muscle cells (VSMCs). Methods and Results— Treatment of VSMCs with PDGF for 24 hours resulted in a loss of caveolin-1 protein expression and plasma membrane–associated caveolae, despite a 3-fold increase in caveolin-1 mRNA. Pretreatment of VSMCs with chloroquine, an inhibitor of lysosomal function, inhibited the PDGF-induced loss of caveolin-1. These studies demonstrated that caveolin-1 was a target of PDGF signaling events. Adenoviral overexpression of caveolin-1 was associated with a switch in PDGF-induced signaling events from a proliferative response to an apoptotic response. This overexpression inhibited PDGF-induced expression of cyclin D1 in the presence of unaffected mitogen-activated protein kinase activation. Conclusions— Taken together, these studies suggest that caveolin-1 is an inhibitor of PDGF proliferative responses and might be capable of transforming PDGF-induced proliferative signals into death signals.